RISK FACTORS FOR RECURRENCES OF CENTRAL SEROUS CHORIORETINOPATHY

被引:54
作者
Matet, Alexandre [1 ]
Daruich, Alejandra [1 ]
Zola, Marta [1 ]
Behar-Cohen, Francine [1 ,2 ]
机构
[1] Univ Lausanne, Dept Ophthalmol, Jules Gonin Eye Hosp, Fdn Asile des Aveugles, Lausanne, Switzerland
[2] Univ Paris 05, INSERM, U1138,Ctr Rech Cordeliers, Team 17,Physiopathol Ocular Dis Clin Dev,Sorbonne, Paris, France
来源
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES | 2018年 / 38卷 / 07期
基金
瑞士国家科学基金会;
关键词
central serous chorioretinopathy; choroidal thickness; circadian rhythm; fluorescein angiography; natural history; recurrences; retinal pigment epithelium; risk factors; shift work; time factors; SUBFOVEAL CHOROIDAL THICKNESS; TERM FOLLOW-UP; FUNDUS AUTOFLUORESCENCE; SPONTANEOUS RESOLUTION; PHOTODYNAMIC THERAPY; TESTOSTERONE LEVELS; DIURNAL-VARIATION; SERUM CORTISOL; VISUAL-ACUITY; DISTRESS;
D O I
10.1097/IAE.0000000000001729
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To describe recurrence patterns and investigate candidate risk factors for recurrences of central serous chorioretinopathy. Methods: In 46 patients with acute central serous chorioretinopathy and follow-up.12 months after first episode resolution, parameters influencing recurrences were retrospectively evaluated using a frailty Cox proportional hazard survival model. Covariates included baseline systemic findings: age, gender, corticosteroid use, stress, shift work, sleep disorder, depression, allergy, cardiovascular risk; baseline optical coherence tomography findings: subfoveal choroidal thickness, pigment epithelial detachment pattern (regular/bump/irregular), number of subretinal hyperreflective foci at leakage site; baseline angiographic findings: fluorescein leakage intensity (intense/moderate/subtle/absent), hyperpermeability pattern on indocyanine-green angiography (focal/multifocal); and episode-related findings: duration and treatment of previous episode. Results: Twenty of 46 subjects (43%) presented >= 1 recurrences during a mean follow-up of 29.9 +/- 9.5 months (range, 15-54 months). Follow-up duration did not differ between cases with or without recurrences (P = 0.3). Worse final visual acuity levels (logarithm of the minimal angle of resolution) were associated with a higher number of episodes during follow-up (P = 0.032, r = 0.28). In a univariate analysis, higher subfoveal choroidal thickness (P = 0.021), nonintense fluorescein leakage (= moderate/subtle/absent, P = 0.033), multiple subretinal hyperreflective foci (P = 0.026), and shift work (P < 0.0001) were significantly associated with recurrences, with a near-significant influence of irregular pigment epithelial detachment (P = 0.093). In a multivariate analysis, higher subfoveal choroidal thickness (P = 0.007), nonintense fluorescein leakage (P = 0.003) and shift work (P < 0.0001) remained significant and independent risk factors for recurrences. Conclusion: Multiple factors influence the risk of central serous chorioretinopathy recurrence. These findings may contribute to identify patients at higher risk, who could benefit from earlier or more intensive treatment.
引用
收藏
页码:1403 / 1414
页数:12
相关论文
共 50 条
  • [31] Risk Factors for Recurrence of Serous Macular Detachment in Untreated Patients with Central Serous Chorioretinopathy
    Fok, Andrew C. T.
    Chan, Poemen P. M.
    Lam, Dennis S. C.
    Lai, Timothy Y. Y.
    OPHTHALMIC RESEARCH, 2011, 46 (03) : 160 - 163
  • [32] Ketoconazole in the Treatment of Central Serous Chorioretinopathy
    Esfahani, Mohammad Riazi
    Torabi, Hamid Reza
    Harandi, Zahra Aalami
    Zarei, Mohammad
    IRANIAN JOURNAL OF OPHTHALMOLOGY, 2010, 22 (04): : 59 - 65
  • [33] Central Serous Chorioretinopathy: Pathogenesis and Management
    Semeraro, Francesco
    Morescalchi, Francesco
    Russo, Andrea
    Gambicorti, Elena
    Pilotto, Andrea
    Parmeggiani, Francesco
    Bartollino, Silvia
    Costagliola, Ciro
    CLINICAL OPHTHALMOLOGY, 2019, 13 : 2341 - 2352
  • [34] CHOROIDAL NEOVASCULARIZATION SECONDARY TO PHOTODYNAMIC THERAPY FOR CENTRAL SEROUS CHORIORETINOPATHY Incidence, Risk Factors, and Clinical Outcomes
    Hwang, Sungsoon
    Noh, Hoon
    Kang, Se Woong
    Kang, Min Chae
    Lee, Dongyoung
    Kim, Sang Jin
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2021, 41 (08): : 1762 - 1770
  • [35] Central Serous Chorioretinopathy: An Update on the Current State of Management
    Kalogeropoulos, Dimitrios
    Shaw, Lincoln
    Skondra, Dimitra
    Ch'ng, Soon Wai
    Christodoulou, Aikaterini
    Kalogeropoulos, Chris
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2024, 241 (07) : 845 - 862
  • [36] Central serous chorioretinopathy in primary hyperaldosteronism
    van Dijk, Elon H. C.
    Nijhoff, Michiel F.
    de Jong, Eiko K.
    Meijer, Onno C.
    de Vries, Aiko P. J.
    Boon, Camiel J. F.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2016, 254 (10) : 2033 - 2042
  • [37] Central Serous Chorioretinopathy: A Review of the Literature
    Prakash, Gunjan
    Chauhan, Nisha
    Jain, Shephali
    Satsangi, Saran Kumar
    ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, 2013, 2 (02): : 104 - 110
  • [38] QUANTITATIVE AUTOFLUORESCENCE IN CENTRAL SEROUS CHORIORETINOPATHY
    Weber, Constance
    Schaetzle, Lea Sophie
    Stasik, Isabel
    von der Emde, Leon
    Holz, Frank G.
    Liegl, Raffael
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2024, 44 (05): : 844 - 851
  • [39] Risk of Recurrence and Transition to Chronic Disease in Acute Central Serous Chorioretinopathy
    Mohabati, Danial
    Boon, Camiel J. F.
    Yzer, Suzanne
    CLINICAL OPHTHALMOLOGY, 2020, 14 : 1165 - 1175
  • [40] Management of chronic central serous chorioretinopathy
    Hanumunthadu, Daren
    Tan, Anna C. S.
    Singh, Sumit Randhir
    Sahu, Niroj Kumar
    Chhablani, Jay
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2018, 66 (12) : 1704 - +